Spin-off founded for the development RNA therapeutics to treat childhood cancer

Joined October 2020
.@PCB_UB : @aptadel raises 2 million euros and prepares a new round to bring the project to the clinical phase stage biotech-spain.com/en/article…
1
1
31
. @aptadel Therapeutics raises 2 million euros and prepares a new round to bring the project to the clinical phase stage capital-riesgo.es/en/article…
1
1
39
🧬 La #innovación impulsa nuevas soluciones en el ámbito terapéutico 🤝Con #AyudasCDTI y los #FondosEuropeos #MRR impulsamos proyectos como el de @aptadel 🔬Desarrollo de una plataforma de aptámeros conjugados con #RNAS terapéuticos para nuevas estrategias frente al #cáncer 👉 aptadeltx.com/ 💡Apoyando con ayudas #NEOTEC: acortar.link/PGAvBD @CienciaGob @P_Recuperacion #AyudandoCrearFuturo #nextgenerationeu #MRR #PRTR #subvención #tecnología #innovación #salud #Agenda2030 #ODS3
4
7
335
🟢 Dr. Gisela Lorente, CEO, @aptadel 🟢 Dr. Héctor Pérez Montoyo, COO & Head of R&D, @AbilityPharma 🟢 @jordifabrega, Co-Founder & CEO, @ConnectaThx
1
2
2
51
@aptadel @TR_Qrem Tolemy bio The present and the future of biotech at @BIOSPAIN_AseBio #BIOSPAIN25
1
1
79
AptadelTx retweeted
New investment in research on Ewing's sarcoma‼️ IDIBELL's spin-off @aptadel Therapeutics receives funding from @LittleWarriorFd to develop RNA-based molecules🧬to find alternative treatments that are more effective and less toxic than current ones More: idibell.cat/en/2025/01/new-i…
4
10
484
AptadelTx retweeted
#canSERV_Userstories Adrian Torres is Head of R&D at @aptadel, which develops RNA-based therapeutics for paediatric cancers. With canSERV’s support, they are spearheading the clinical development. Explore how canSERV can advance YOUR own research. ➡️canserv.eu
2
4
119
List of approved RNA based drugs
12
1
57
4,184
AptadelTx retweeted
💬 Mercè de Frias, PhD, MBA, COO @OnaTherapeutics: “At the moment when we got awarded our team was growing. The program helped us consolidate it”.
1
3
7
213
AptadelTx retweeted
💬 Gisela Lorente, CSO @aptadel: “The program allowed us perform our own science and not having to rely that much in external sources”.
1
3
6
223
AptadelTx retweeted
💬 Marina Rigau, CEO & Co-founder @mimarkdx: “I really appreciate the training offered by the program and specially the fact that trains the whole team and to just the C Levels”.
3
7
212
🔛 El programa #BCNHealthBooster és un èxit! 💬 María Terrades Palomar, CEO del @PCB_UB, ha confirmat a #BIOSPAIN2023 que "veient els indicadors destacats, és hora de començar a pensar en la propera edició del programa". Més detalls 👇🔗 biocat.cat/ca/noticies/les-e…
1
1
6
336
🗣️@nmarti1212 (#Biocat), ha conversat amb les representants de 3 de les startups seleccionades @OnaTherapeutics, @aptadel i @mimarkdx i ha assegurat que “al llarg dels propers dos anys, seguirem ajudant a les empreses a aconseguir el seu màxim potencial”
2
2
174
AptadelTx retweeted
💡 In 2022 the accelerator selected 11 companies having impact projects: @aptadel, @Dannabiotech, Bioliquid Innovative Genetics, SL., deepull, GAT BIOSCIENCES S.L, GAT Therapeutics, @mimarkdx, Nuage Therapeutics, ONA Therapeutics, @zymvol Biomodeling & @onechaintx.
1
3
4
248
AptadelTx retweeted
🔛 #BCNHealthBooster is a success! The program accelerates #health companies by offering access to a lab in the @PCB_UB & training by #Biocat 💬 María Terrades, DG of PCB, said at #BIOSPAIN2023 that "looking at the outstanding indicators, it's time to think in the next edition".
1
4
4
573
Continuem amb una #taularodona moderada per Núria Martí, directora d'innovació de @biocat_cat. Debatem sobre el potencial del #BCNHealthBooster amb representants i referents del sector: 🔷 @mercedfs d'@OnaTherapeutics 🔷 @RigauMarina de @mimarkdx 🔷 Gisela Lorente d'@aptadel
1
3
8
736